A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
Trial details
- Registry ID
- NCT07354724
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe DiseaseNCT07354724 | DNLI | Phase 1, Phase 2 | Recruiting | 2028-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |